Company Overview - Anixa Biosciences, Inc. (NASDAQ: ANIX) focuses on developing immunotherapies for cancer through two main platforms: a CAR-T program aimed at solid tumors and a vaccine technology that generates tumor-specific antigens [1]. Partnerships - Anixa has established partnerships with the Moffitt Cancer Center, which may enhance its research and development capabilities in the field of cancer immunotherapy [1].